• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. PERMCATH; CATHETER, SUBCLAVIAN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. PERMCATH; CATHETER, SUBCLAVIAN Back to Search Results
Model Number 8817748001
Medical Device Problem Code Break (1069)
Health Effect - Clinical Codes Unintended Radiation Exposure (4565); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/12/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
According to the reporter, during the patient's dialysis, the doctor found that there was blood leak from the tunnel entrance, and the catheter was broken near the kraft (cuff/sleeve/near the tip of the tube) which was near the blood vessel.Angiography was done during surgery.The catheter was still complete, not divided into several parts and no pieces.No other defects/damages were found on the product where the leak was observed.Flushing was done on the device prior to use and the result was normal.No other products were being utilized with the device.Nothing unusual was observed on the device prior to use.The catheter was not repaired, no cleaning agent was used on the device, no tego was utilized, and no luer adapter issue.The insertion site was not treated prior to product placement.Blood transfusion was not required.They extubated, replaced the product and reinsertion/reoperation was done with the new catheter of the same brand and lot on the same day as intervention to resolve the issue.The new catheter was used successful ly and the procedure was completed.
 
Event or Problem Description
According to the reporter, during the patient's dialysis, the doctor found that there was blood leak from the tunnel entrance, the catheter was broken near the kraft (cuff/sleeve/near the tip of the tube) which was near the blood vessel.Angiography was done during surgery and it was a step in the operation.The catheter was still complete, not divided into several parts and no pieces.No other defects/damages found on the product where the leak was observed.Flushing was done on the device prior to use and the result was normal.No other products were being utilized with the device.Nothing unusual was observed on the device prior to use.The catheter was not repaired, no cleaning agent used on the device, no tego utilized, and no luer adapter issue.The insertion site was not treated prior to product placement.Blood transfusion was not required.They extubated, replaced the product and reinsertion/reoperation was done with the new catheter of the same brand and lot on the same day as intervention to resolve the issue.The new catheter was used successfully and the procedure was completed.The patient was stable.There was no patient injury.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
H3: evaluation summary: medtronic conducted an investigation based upon all information received.The involved device was not returned.However, a video was provided.Visual inspection noted the cannula was found to have a leak.It was reported that there is a leak on the catheter shaft.The reported issue was confirmed.The most likely cause was traced to a maintenance issue.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Evaluation summary: medtronic conducted an investigation based upon all information received.The involved device was not returned.However, a video was provided.Visual inspection noted the cannula had a leak.It was reported that there was a leak on the catheter shaft.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Hold for cr 10/17.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERMCATH
Common Device Name
CATHETER, SUBCLAVIAN
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CS  20101
MDR Report Key11271620
Report Number3009211636-2021-00030
Device Sequence Number4188734
Product Code LFJ
UDI-Device Identifier10884521009868
UDI-Public10884521009868
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K871942
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 07/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/12/2022
Device Model Number8817748001
Device Catalogue Number8817748001
Device Lot Number1722100105
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/15/2021
Initial Date Received by Manufacturer 01/12/2021
Supplement Date Received by Manufacturer01/27/2021
05/05/2021
07/14/2021
Initial Report FDA Received Date02/03/2021
Supplement Report FDA Received Date02/24/2021
05/27/2021
07/22/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-